QPT — Quest PharmaTech Share News
0.000.00%
Last trade - 00:00- CA$3.38m
- CA$4.30m
Brief: Quest Pharmatech Provides Product Development Update
Brief: Quest PharmaTech Clarifies Agreement in Principle with OQP Bio
Brief: Quest Pharmatech Provides Corporate Update
Brief: Quest PharmaTech Announces Sale Of Bioceltran Investment And Return Of Photodynamic Therapy Technology License
Pharmatech Exscientia jumps in U.S. stock market debut
Insight: How South Korea turbocharged specialty syringe production for COVID-19 vaccines
Brief: Quest Provides Update To Immunotherapy Asset Transfer Between Oncoquest Inc. And Oncoquest Pharmaceuticals Inc.
Brief: OncoQuest Signs Deal To Sell Drug Portfolio To Dual Industrial For $300 Mln
Brief: Oncoquest Announces Publication Of Two Reports Related To Oregovomab Phase 2 Clinical Trial
Brief: Oncoquest Receives "Notice Of Allowance" For Patent Protection Of Administration Schedule Of Oregovomab And Chemotherapy For Stage III-IV Ovarian Cancer Patients
Brief: OncoQuest Retains Services Of IQVIA To Manage Phase 3 Study In Frontline Ovarian Cancer
Brief: Quest Pharmatech Adopts Amendment To By-Laws Requiring Advance Notice Of Nomination Of Directors
Brief: Quest Pharmatech Signs License Agreement With Oncocare Therapeutics
Brief: Madenco Biosciences Announces Strategic Decision To Drop Consumer Health Products
Brief: Quest Pharmatech Unit Sign License Agreement With Stanford University
Brief: Oncoquest announces enrollment of first patient in phase 1/2 clinical study
Brief: Quest PharmaTech to acquire 32% of Natural Rf Life Sciences common stock
Brief: Oncoquest initiates commercial scale Oregovomab manufacturing program
Brief: Quest Pharmatech says positive interim results from mid-stage clinical study of Oregovomab